Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01071473 · ClinicalTrials.gov registry record · NA

Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy

A NA study of Cardiomyopathy, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT01071473: Completed NA study of Cardiomyopathy, sponsored by St. Jude Children's Research Hospital.

NCT01071473 is a NA study of Cardiomyopathy that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 22 participants, below the 556-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01071473, a NA study of Cardiomyopathy, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This application proposes a prospective, single arm feasibility clinical trial of a 12-week period of combined endurance and resistance training in survivors of childhood cancer who were treated with doxorubicin and/or daunorubicin and have impaired cardiac function. Baseline and post intervention imaging, laboratory, and neuropsychological evaluations will be used to determine the effects of the intervention on body composition, serum lipid profile, exercise tolerance, and neurocognitive functioning. Participants will be called weekly to monitor compliance with the intervention. Incentives will be given at intervals during the trial to optimize compliance with the intervention.

Conditions Studied

Interventions

  • OTHER 12 Week Exercise Intervention

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2010-02
Est. Completion 2012-10
Phase NA

What the finished NCT01071473 record still lists

NCT01071473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 556-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which 12 Week Exercise Intervention is the first listed.

NCT01071473 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT01071473 about?

NCT01071473 is a clinical study titled "Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy". This application proposes a prospective, single arm feasibility clinical trial of a 12-week period of combined endurance and resistance training in survivors of childhood cancer who were treated with doxorubicin and/or daunorubicin and have impaired cardiac function. Baseline and post intervention ...

What is the current status of trial NCT01071473?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2010-02. Estimated completion is 2012-10.

What conditions does trial NCT01071473 study?

This clinical trial studies the following conditions: Cardiomyopathy.

What interventions are being tested in trial NCT01071473?

The interventions under investigation include: 12 Week Exercise Intervention (OTHER).

Who is sponsoring clinical trial NCT01071473?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01071473 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiomyopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01071473's enrollment target sits among peer trials

22 23rd of 25 higher than 3 of 25 other Cardiomyopathy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiomyopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01071473, the US trial registry maintained by the National Library of Medicine. NCT01071473 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.